[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526069":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":61,"collaborators":26,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":26,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":26,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":26,"overallStatus":43,"whyStopped":26,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Second Affiliated Hospital of Soochow University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dim light group","PLACEBO_COMPARATOR","treated with the placebo device which operates with one intensity of 300 lux \\* 1 month",[13],"Device: Dim Light box",{"label":15,"type":16,"description":17,"interventionNames":18},"Bright light group","EXPERIMENTAL","treated with the experimental device which operates with one intensity of 10,000 lux \\* 1 month",[19],"Device: Bright light box",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Bright light box","The light box uses a spectrally transparent prism diffuser, which can block ultraviolet rays, but will not affect the quality of the filtered light and will not turn yellow. The distance between the light box and the patient should not exceed 65cm.PD patients are selected for light intervention of different intensities. The experimental group is treated with 10,000 Lux intensity. The treatment time is 1 hour each day from 08:00-11:00 in the morning and 17:00-19:00 in the afternoon lasting for a month. The patient is asked to move under the light source, but should not fall asleep.",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Dim Light box","The light box uses a spectrally transparent prism diffuser, which can block ultraviolet rays, but will not affect the quality of the filtered light and will not turn yellow. The distance between the light box and the patient should not exceed 65cm.PD patients are selected for light intervention of different intensities. The control group is treated with 300 Lux intensity. The treatment time is 1 hour each day from 08:00-11:00 in the morning and 17:00-19:00 in the afternoon lasting for a month. The patient is asked to move under the light source, but should not fall asleep.",[9],[32],{"name":33,"affiliation":5,"role":34},"Chun-Feng Liu, PhD","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","+86 512 67783307","liuchunfeng@suda.edu.cn",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Department of Neurology, Second Affiliated Hospital of Soochow University","RECRUITING","Suzhou","Jiangsu","215004","China","CN",{"type":50,"coordinates":51},"Point",[52,53],120.59538,31.30408,{"lat":53,"lon":52},[56,59],{"name":57,"role":37,"phone":58,"phoneExt":26,"email":39},"Chun-Feng Liu, Ph.D, M.D.","00 86 512 67783307",{"name":60,"role":34,"phone":26,"phoneExt":26,"email":26},"Chun-Feng Liu, Ph.D,M.D.",{"type":34,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Chun-Feng Liu","Professor","100526069","light-therapy-in-parkinsons-disease-100526069",false,"NCT06129942","Light Therapy in Parkinson's Disease","Light Therapy in Parkinson's Disease: a Prospective, Observational Study","Inclusion Criteria:\n\n* According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3.\n* All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period.\n\nExclusion Criteria:\n\n* Using hypnotic or stimulating drugs.\n* Using antidepressants, except stable drugs maintained for more than three months;\n* Visual impairment, such as cataract, glaucoma, blindness, etc;\n* Cognitive impairment (MMSE \\\u003C 24);\n* There are uncontrollable hallucinations and mental diseases;\n* There are sleep phase delay \u002F advance syndrome, shift work, jet lag, etc","ALL","50 Years","80 Years",{"count":75,"type":76},50,"ESTIMATED","INTERVENTIONAL",[79],"NA","The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.",[82,83,84],"Parkinson Disease","Sleep Disorder","Circadian Rhythm Disorders","2025-02-11",{"date":87,"type":88},"2025-02-12","ACTUAL",{"date":90,"type":88},"2021-09-01",{"date":92,"type":76},"2026-05-16",{"name":5,"class":6},1]